Caris Molecular Intelligence®, our patented and proprietary offering, provides reliable and actionable information that serves as a molecular blueprint to help oncologists personalize cancer therapy and improve care for their patients.

  • MI Profile is a multi-platform, solid tumor biomarker analysis platform for therapeutic decision support and clinical trials matching (IHC; CISH; FISH; 46- and 592-gene Next-Generation Sequencing; Pyro Sequencing; Fragment Analysis).

MI Profile tumor profiling identifies biomarker to drug associations for more than 60 FDA-approved therapies, including immunotherapies, targeted therapies and chemotherapeutics. Individual biomarkers are also available and may be ordered in addition to MI Profile.

For a complete list of profiles details, please view the current profile menu at www.CarisMolecularIntelligence.com/profilemenu.